en

PRODUCT DETAIL

Abilify Maintena 400 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním

Code 8419A
MA number EU/1/13/882/002
Product Form: plu igf 1x400 mg+1x2 ml+samost.bal.(liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Otsuka Pharmaceutical Netherlands B.V., Netherland
Therapeutic Class: 68 - ANTIPSYCHOTICA (NEUROLEPTICA)
ATC:
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05A ANTIPSYCHOTICS
N05AX Other antipsychotics
N05AX12 Aripiprazole
Shelf life: 36
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 15.11.2013
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 24.04.2024
eu-flag.png sk-flag.png